SEC Form 4 · accession 0001437749-18-020632

NATIONAL HEALTHCARE CORP · NHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Nov 8, 2018

Accepted (ET)

Nov 13, 2018 · 5:25 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001047335

Table I — non-derivative securities

Security	Date	Code	Shares	A/D	Owned after	D/I	Nature of ownership
Common Stock - Held in my name or my wife's name	holding	—	—	—	194,720	D
Common Stock - Family LP (BFLP)	holding	—	—	—	29,523	I	General Partner
Common Stock - Fam. Partnership (LR Ent.)	holding	—	—	—	31,698	D
Common Stock - Fam. Partnership (LFLP)	holding	—	—	—	96,000	I	General Partner

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Option to purchase common stock^F1	$52.93	Nov 8, 2018	D	7,500	D	—	May 7, 2019	Common Stock	7,500	0	D
Option to purchase common stock^F1	$52.93	Nov 8, 2018	A	7,500	A	—	May 7, 2019	Common Stock	7,500	7,500	D
Option to purchase common stock^F1	$61.25	Nov 8, 2018	D	7,500	D	—	May 6, 2020	Common Stock	7,500	0	D
Option to purchase common stock^F1	$61.25	Nov 8, 2018	A	7,500	A	—	May 6, 2020	Common Stock	7,500	7,500	D
Option to purchase common stock^F1	$62.78	Nov 8, 2018	D	7,500	D	—	Jun 1, 2021	Common Stock	7,500	0	D
Option to purchase common stock^F1	$62.78	Nov 8, 2018	A	7,500	A	—	Jun 1, 2021	Common Stock	7,500	7,500	D
Option to purchase common stock^F1	$72.94	Nov 8, 2018	D	7,500	D	—	May 8, 2022	Common Stock	7,500	0	D
Option to purchase common stock^F1	$72.94	Nov 8, 2018	A	7,500	A	—	May 8, 2022	Common Stock	7,500	7,500	D
Option to purchase common stock^F1	$61.90	Nov 8, 2018	D	7,500	D	—	May 2, 2023	Common Stock	7,500	0	D
Option to purchase common stock^F1	$61.90	Nov 8, 2018	A	7,500	A	—	May 2, 2023	Common Stock	7,500	7,500	D

F1The reported transactions involve an amendment to five outstanding options resulting in the deemed cancellation of each of the "old" options and the grant of replacement options. On November 8, 2018, the Board of Directors amended each of the options to allow a director that has served as a director for at least 12 years to remain able to exercise the option for the full term of the option even if the director retires, resigns, dies or becomes disabled. Each of the options were fully exercisable on the date of grant. The grant and exercise of these options are exempt from Section 16(b) pursuant to Rule 16b-3(d).